Has $TRIL ever suggested a reason for WHY its drugs don't bind to human red blood cells?

2017 paper in deck suggests: "association of #CD47 w erythrocyte spectrin cytoskeleton, which results in reduced membrane mobility & failure to cluster CD47 effectively"

$ALXO $IMAB $STTK
https://twitter.com/Varro_Analytics/status/1329774120448495618
^Sentence after that one in the 2017 paper:

"Consistent with this theory, we have previously shown strong binding of $TRIL TTI-621 to human erythrocytes when #CD47 is first preclustered using a nonblocking CD47 antibody"

$ALXO $IMAB $STTK

2014 paper: https://cancerres.aacrjournals.org/content/74/19_Supplement/5011
You can follow @Varro_Analytics.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.